Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization

Oncogene. 2006 Nov 23;25(55):7274-88. doi: 10.1038/sj.onc.1209714. Epub 2006 Jun 5.

Abstract

Nucleolin is a c-Myc-induced gene product with defined roles in ribosomal RNA processing and the inhibition of chromosomal DNA replication following stress. Here we find that changes in nucleolin protein levels in unstressed cells cause parallel changes in the amount of p53 protein. Alterations in p53 levels arise from nucleolin binding to the p53 antagonist Hdm2, resulting in the inhibition of both p53 ubiquitination and Hdm2 auto-ubiquitination. Nucleolin does not alter p53 ubiquitination by human papillomavirus E6, indicating that the effect is specific for Hdm2. Although the inhibition of ligase activity would be expected to stabilize Hdm2, we instead find that nucleolin also reduces Hdm2 protein levels, demonstrating that nucleolin inhibits Hdm2 using multiple mechanisms. Increases in nucleolin levels in unstressed cells led to higher expression of p21(cip1/waf1), a reduced rate of cellular proliferation, and an increase in apoptosis. Thus, nucleolin has a number of properties in common with the tumor suppressor ARF (alternate reading frame). We propose that nucleolin, like ARF, responds to hyperproliferative signals by upregulation of p53 through Hdm2 inhibition.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blotting, Western
  • Cell Line
  • Down-Regulation
  • Half-Life
  • Humans
  • Immunoprecipitation
  • In Situ Nick-End Labeling
  • Nucleolin
  • Phosphoproteins / physiology*
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors*
  • RNA-Binding Proteins / physiology*
  • Tumor Suppressor Protein p53 / physiology*
  • Ubiquitin / metabolism

Substances

  • Phosphoproteins
  • RNA-Binding Proteins
  • Tumor Suppressor Protein p53
  • Ubiquitin
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2